Despite Surgeon Support, NEJM Vertebroplasty Articles Spark Slowdown, Reimbursement Review
Executive Summary
Two controversial clinical studies published in the New England Journal of Medicine are forcing Medtronic and Orthovita to convince primary care physicians of the benefits of kyphoplasty and vertebroplasty.
You may also be interested in...
Medtronic Looks to Strengthen Spine with Osteotech Purchase
Medtronic, struggling to hold onto its sizable share of the shrinking spinal market, made a bid for publicly traded Osteotech, a maker of a demineralized bone matrix agent that will broaden the company's regenerative product portfolio.
Welsh Carson Sits in K2M Driver's Seat
With the backing of the private equity powerhouse Welsh Carson, K2M will look to grow beyond its historical niche in complex spinal cases, though it will have to do so without any financial ties to the surgeons who once owned part of the company.
Welsh Carson Sits in K2M Driver's Seat
With the backing of the private equity powerhouse Welsh Carson, K2M will look to grow beyond its historical niche in complex spinal cases, though it will have to do so without any financial ties to the surgeons who once owned part of the company.